• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.

作者信息

Stern W H, Lewis G P, Erickson P A, Guerin C J, Anderson D H, Fisher S K, O'Donnell J J

出版信息

Am J Ophthalmol. 1983 Jul;96(1):33-42. doi: 10.1016/0002-9394(83)90452-x.

DOI:10.1016/0002-9394(83)90452-x
PMID:6869478
Abstract

Fluorouracil effectively inhibits epiretinal membrane formation and traction retinal detachment after vitrectomy surgery. When 0.5 mg of fluorouracil was administered intraocularly every 24 hours for seven days, traction retinal detachment two weeks after the intraocular injection of 200,000 cultured retinal pigment epithelial cells occurred in 12 of 12 control eyes but in only six of 14 eyes treated with fluorouracil (P less than .001). Four weeks after cell injection, eight of 12 eyes treated with fluorouracil had traction retinal detachments whereas 12 of 12 control eyes did (P less than .001). The height of the traction retinal detachment four weeks after intraocular injection of 200,000 cultured retinal pigment epithelial cells was reduced 50% in eyes treated with 0.5 mg of fluorouracil every 24 hours for seven days compared to control eyes (P less than .001). When the number of injected retinal pigment epithelial cells was increased to 400,000 cells and 1.25 mg of fluorouracil was administered intraocularly every 24 hours for seven days, traction retinal detachment two weeks after injection occurred in 15 of 15 eyes in the control group but in none of ten eyes in the treated group. Four weeks after cell injection, eight of eight eyes in the control group and five of five eyes in the fluorouracil-treated group had detachments and the mean height of the detachments in the two groups was equal. Autoradiography of the epiretinal membranes in eyes injected with 200,000 cultured retinal pigment epithelial cells and labeled for two hours with tritiated thymidine showed that 0.8% of the epiretinal cell nuclei were labeled two weeks after cell injection but that no labeled cells were present in the fluorouracil-treated eyes. Tritiated thymidine labeling of epiretinal cells in the fluorouracil-treated eyes was first noted three weeks after the cell injection. The presence of tritiated thymidine labeling in the fluorouracil-treated eyes correlated with an increase in the number of epiretinal cells and an increase in the incidence of traction retinal detachment.

摘要

相似文献

1
Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.
Am J Ophthalmol. 1983 Jul;96(1):33-42. doi: 10.1016/0002-9394(83)90452-x.
2
Epiretinal membrane formation after vitrectomy.
Am J Ophthalmol. 1982 Jun;93(6):757-72. doi: 10.1016/0002-9394(82)90472-x.
3
The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy.血视网膜屏障破坏在增殖性玻璃体视网膜病变细胞注射模型中的作用。
Arch Ophthalmol. 1988 Sep;106(9):1291-4. doi: 10.1001/archopht.1988.01060140451051.
4
Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy.
Am J Ophthalmol. 1983 May;95(5):663-7. doi: 10.1016/0002-9394(83)90387-2.
5
Bovine RPE heterotransplants simulate proliferative vitreoretinopathy (PVR) in rabbits.
Metab Pediatr Syst Ophthalmol (1985). 1987;10(1):2-8.
6
Ocular toxicity of fluorouracil after vitrectomy.玻璃体切除术后氟尿嘧啶的眼部毒性
Am J Ophthalmol. 1983 Jul;96(1):43-51. doi: 10.1016/0002-9394(83)90453-1.
7
Pharmacological therapy for proliferative vitreoretinopathy.增殖性玻璃体视网膜病变的药物治疗
Graefes Arch Clin Exp Ophthalmol. 1986;224(3):230-3. doi: 10.1007/BF02143060.
8
N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina.
Exp Eye Res. 1993 Apr;56(4):489-95. doi: 10.1006/exer.1993.1062.
9
Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.使用可生物降解的玻璃体内植入物持续释放氟尿嘧啶预防实验性增殖性玻璃体视网膜病变。
Arch Ophthalmol. 1994 Mar;112(3):407-13. doi: 10.1001/archopht.1994.01090150137036.
10
Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
Invest Ophthalmol Vis Sci. 1993 Apr;34(5):1753-60.

引用本文的文献

1
Efficacy of 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) in high-risk pediatric retinal detachment; randomized clinical trial.5-氟尿嘧啶(5-FU)与低分子量肝素(LMWH)用于高危儿童视网膜脱离的疗效;随机临床试验
BMC Ophthalmol. 2024 Mar 4;24(1):97. doi: 10.1186/s12886-024-03362-4.
2
Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid.眼外伤后增生性玻璃体视网膜病变:生长因子和细胞因子的过度表达导致视网膜瘢痕形成。
Mediators Inflamm. 2013;2013:269787. doi: 10.1155/2013/269787. Epub 2013 Sep 30.
3
Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo.
体外和体内评估折叠式囊袋玻璃体中的 5-氟尿嘧啶释放。
Graefes Arch Clin Exp Ophthalmol. 2012 May;250(5):751-9. doi: 10.1007/s00417-011-1862-y. Epub 2011 Nov 27.
4
Specific role of lymphatic marker podoplanin in retinal pigment epithelial cells.淋巴管标志物 podoplanin 在视网膜色素上皮细胞中的特定作用。
Lymphology. 2010 Sep;43(3):128-34.
5
Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor.玻璃体内控释药物对流与扩散传输的计算机模拟
Pharm Res. 2003 Jan;20(1):96-102. doi: 10.1023/a:1022207026982.
6
Permeability and diffusion in vitreous humor: implications for drug delivery.玻璃体液中的渗透性与扩散:对药物递送的影响
Pharm Res. 2000 Jun;17(6):664-9. doi: 10.1023/a:1007517912927.
7
Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy.细胞间黏附分子1(ICAM-1)的玻璃体水平作为增殖性玻璃体视网膜病变的风险指标。
Br J Ophthalmol. 1999 Aug;83(8):953-6. doi: 10.1136/bjo.83.8.953.
8
Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU.通过眼内持续递送5-氟尿嘧啶抑制实验性增殖性玻璃体视网膜病变
Int Ophthalmol. 1995;19(1):43-9. doi: 10.1007/BF00156419.
9
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.增殖性玻璃体视网膜病变:病理生物学、手术治疗及辅助治疗
Br J Ophthalmol. 1995 Oct;79(10):953-60. doi: 10.1136/bjo.79.10.953.
10
Extended retinal tamponade in the treatment of retinal detachment with proliferative vitreoretinopathy.增殖性玻璃体视网膜病变性视网膜脱离的长效视网膜填塞治疗
Br J Ophthalmol. 1986 Dec;70(12):911-7. doi: 10.1136/bjo.70.12.911.